(Q43729604)

English

Assessment of the response of patients with Crohn's disease to biological therapy using new non-invasive markers: lactoferrin and calprotectin

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Assessment of the response of patients with Crohn's disease to biological therapy using new non-invasive markers: lactoferrin and calprotectin (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Crohn's disease

1 reference

based on heuristic

inferred from title

author name string

Islaine Martins Nogueira

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sender Jankiel Miszputen

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Orlando Ambrogini Jr

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Ricardo Artigiani-Neto

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Cláudia Teresa Carvente

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Maria Ivani Zanon

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Arquivos de Gastroenterologia

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

130-137

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Enzymes in feces: useful markers of chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Diagnosis and assessment of Crohn's disease: the present and the future.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Fecal lactoferrin: a new parameter to monitor infliximab therapy.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Update of the management of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Long-term natural history of Crohn's disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Review article: Crohn's disease: monitoring disease activity

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Review of fecal biomarkers in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

A simple method for assessing intestinal inflammation in Crohn's disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013000200022

21 January 2018

Identifiers

10.1590/S0004-28032013000200022

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43729604&oldid=2102886494"